iStent Inject for Glaucoma

IStent Inject

iStent Injects are a type of Minimally Invasive Glaucoma Surgery (MIGS). Following implantation, they lower the IOP by increasing drainage of the intraocular fluid (aqueous humour) through the implants hence reducing the eye pressure. They have shown promising results in the short-to-medium term, and have a higher safety profile and faster recovery time than conventional glaucoma surgeries, as there is minimal tissue disruption.

As there is less IOP reduction compared to conventional glaucoma surgeries, these procedures are targeted at patients with mild to moderate glaucoma. They can be performed together with cataract surgery, or as a stand-alone procedure. Hence, this is a good option to consider for patients with cataracts and early to moderate glaucoma, as it can potentially reduce the number of glaucoma medications after surgery. When performed at the same time as cataract surgery, there are no additional cuts or wounds, hence patients can expect the same recovery time as cataract surgery alone. 

The iStent was the first MIGS device to be FDA-approved, and the iStent Inject is a newer device with a modified injector that can be simultaneously loaded with 2 stents (Figure 1). Each titanium stent measures 0.36 by 0.23 millimetres and it is the smallest medical device known to be implanted in the human body (Figure 2). The stents are inserted into the drainage canals to allow increased outflow of fluid from the eye (Figure 3).

 
Figure 1. iStent inject stents and the iStent inject trabecular micro-bypass stent system
APEC-Asia-Pacific-Eye-Centre-Glaucoma-iStent-Inject-2-Glaukos-Penny
Figure 2. The iStent inject stents, being the smallest medical device known to be implanted in the human body.

Restores Natural Outflow Pathway

When implanted, the iStent inject® creates two patent bypass pathways through the trabecular meshwork — the main source of resistance for aqueous outflow—resulting in multi-directional flow through Schlemm’s canal. 

Glaucoma-iStent-Inject-Process-Animation-1024x580

FAQ

A prospective multicentre study has found that following implantation of 2 iStent Injects, majority of the patients (86.9%) achieved a reduction in the number of glaucoma medications. There were few to no adverse events reported following implantation of the iStent Inject. In fact, a combined cataract surgery with iStent Injects has a safety profile similar to cataract surgery alone.

Glaucoma Screening & Testing

Glaucoma Screening

$ 80
(Exclusive GST)
  •  
$ 87 20
(Inclusive GST)
  •  

*Does not include consultation with Doctor. 

Cataract/Glaucoma/Age-Related Macular Degeneration Screening

$ 200
(Exclusive GST)
  •  
$ 218
(Inclusive GST)
  •  

Our Glaucoma Specialist

Dr. Tan Yar Li

MBBS (Singapore), M.Med (Ophth)
MRCSEd (Ophth), FAMS (Ophth)
Senior Consultant | Eye Surgeon
Sub-specialties: Glaucoma, Cataract, Refractive Surgery (LASIK)
Languages: English, Mandarin, Hokkien, Teochew

Fellowship Trained Specialist


Former Consultant at Singapore National Eye Centre (SNEC)

Former Deputy Head of the Department of Ophthalmology at Changi General Hospital

Dr Tan obtained her Bachelor in Medicine and Surgery (MBBS) from the National University of Singapore. Thereafter, she did Ophthalmology residency training in Singapore and qualified as a Member of the Royal College of Surgeons of Edinburgh. She obtained her Master of Medicine (Ophthalmology) qualifications from NUS and completed a further 3 years of advance surgical training at the Singapore National Eye Centre.

Dr Tan obtained her specialist accreditation as a Fellow of the Academy of Medicine, Singapore (FAMS), where she was awarded 3 gold medals for Best Candidate in Glaucoma, Vitreoretinal as well as Neuro-ophthalmology in the Eye Specialists’ Exit exam. After having obtained her specialist accreditation, she also successfully completed her Glaucoma subspecialty fellowship training at the Singapore National Eye Centre.

Dr Tan has more than a decade of ophthalmology experience and her current clinical practice includes general ophthalmology, cataract and refractive surgery (LASIK and advanced surface ablation) as well as in the subspecialty field of Glaucoma. She is well-versed in performing cataract surgery with implantation of multifocal and toric intraocular lens for the correct of myopia, astigmatism and presbyopia.

Her current area of interest is in Minimally Invasive Glaucoma Surgery (MIGS) and she was also one of the first few surgeons in Singapore to perform these surgeries.

Prior to her current appointment, Dr Tan was a consultant ophthalmologist at the Glaucoma department of the Singapore National Eye Centre and Deputy Head of the Department of Ophthalmology at Changi General Hospital. She was also actively involved in the teaching of medical students, residents as well as paramedical staff. Dr Tan is currently a visiting consultant at the Singapore National Eye Centre.

Dr Tan genuinely cares for and listens to her patients as she firmly believes that patients’ outcome is the most important, and this can be only be achieved when there is a good doctor-patient relationship, which is the keystone to good medical care. Outside of work, she is a mother to 2 lovely kids and she is an avid runner and baker during her spare time.

Book a Consultation

Get an eye checkup with us now!

Interested to fix a consult with our eye specialist? Get in touch with us!

Book a Consultation

Get an eye checkup with us now!

Interested to fix a consult with our eye specialist? Get in touch with us!